{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:40:43Z","timestamp":1793673643307,"version":"4.5.1"},"reference-count":279,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1038\/nrneurol.2017.185","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T10:22:22Z","timestamp":1517221342000},"page":"168-181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1543,"title":["Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums"],"prefix":"10.1038","volume":"14","author":[{"given":"Steven E.","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Arvanitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Macauley-Rambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoau-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rexford S.","family":"Ahima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Craft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Gandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke E.","family":"Stoeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Holtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"BFnrneurol2017185_CR1","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jalz.2014.10.008","volume":"11","author":"HM Snyder","year":"2015","unstructured":"Snyder, H. M. et al. Vascular contributions to cognitive impairment and dementia including Alzheimer's disease. Alzheimers Dement. 11, 710\u2013717 (2015).","journal-title":"Alzheimers Dement."},{"key":"BFnrneurol2017185_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1212\/WNL.0000000000000733","volume":"83","author":"TJ Montine","year":"2014","unstructured":"Montine, T. J. et al. Recommendations of the Alzheimer's disease-related dementias conference. Neurology 83, 851\u2013860 (2014).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR3","first-page":"353","volume":"5","author":"LE Stoeckel","year":"2016","unstructured":"Stoeckel, L. E. et al. Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction. F1000Res. 5, 353 (2016).","journal-title":"F1000Res."},{"key":"BFnrneurol2017185_CR4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2337\/dc15-1588","volume":"39","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee, S. et al. Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care 39, 300\u2013307 (2016).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR5","first-page":"607","volume":"24","author":"C Gao","year":"2013","unstructured":"Gao, C., Liu, Y., Li, L. & Holscher, C. New animal models of Alzheimer's disease that display insulin desensitization in the brain. Rev. Neurosci. 24, 607\u2013615 (2013).","journal-title":"Rev. Neurosci."},{"key":"BFnrneurol2017185_CR6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/archneurol.2012.1117","volume":"69","author":"K Yaffe","year":"2012","unstructured":"Yaffe, K. et al. Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch. Neurol. 69, 1170\u20131175 (2012).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2017185_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","volume":"5","author":"GJ Biessels","year":"2006","unstructured":"Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C. & Scheltens, P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5, 64\u201374 (2006).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol2017185_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2337\/diacare.24.2.366","volume":"24","author":"A Fontbonne","year":"2001","unstructured":"Fontbonne, A., Berr, C., Ducimetiere, P. & Alperovitch, A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24, 366\u2013370 (2001).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/bmj.37977.495729.EE","volume":"328","author":"G Logroscino","year":"2004","unstructured":"Logroscino, G., Kang, J. H. & Grodstein, F. Prospective study of type 2 diabetes and cognitive decline in women aged 70\u201381 years. BMJ 328, 548 (2004).","journal-title":"BMJ"},{"key":"BFnrneurol2017185_CR10","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archneur.64.4.570","volume":"64","author":"JA Luchsinger","year":"2007","unstructured":"Luchsinger, J. A. et al. Relation of diabetes to mild cognitive impairment. Arch. Neurol. 64, 570\u2013575 (2007).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2017185_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000064928","volume":"14","author":"C MacKnight","year":"2002","unstructured":"MacKnight, C., Rockwood, K., Awalt, E. & McDowell, I. Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement. Geriatr. Cogn. Disord. 14, 77\u201383 (2002).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"BFnrneurol2017185_CR12","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott, A. et al. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53, 1937\u20131942 (1999).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3233\/JAD-2012-120106","volume":"30","author":"R Ravona-Springer","year":"2012","unstructured":"Ravona-Springer, R. et al. Changes in glycemic control are associated with changes in cognition in non-diabetic elderly. J. Alzheimers Dis. 30, 299\u2013309 (2012).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2017185_CR14","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181ffe4f6","volume":"75","author":"EM Schrijvers","year":"2010","unstructured":"Schrijvers, E. M. et al. Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study. Neurology 75, 1982\u20131987 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S0895-4356(03)00077-5","volume":"56","author":"JH Wu","year":"2003","unstructured":"Wu, J. H. et al. Impact of diabetes on cognitive function among older Latinos: a population-based cohort study. J. Clin. Epidemiol. 56, 686\u2013693 (2003).","journal-title":"J. Clin. Epidemiol."},{"key":"BFnrneurol2017185_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S1047-2797(02)00464-7","volume":"13","author":"JH Wu","year":"2003","unstructured":"Wu, J. H. et al. Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann. Epidemiol. 13, 369\u2013376 (2003).","journal-title":"Ann. Epidemiol."},{"key":"BFnrneurol2017185_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2337\/diacare.26.2.314","volume":"26","author":"JH Wu","year":"2003","unstructured":"Wu, J. H. et al. Diabetes as a predictor of change in functional status among older Mexican Americans: a population-based cohort study. Diabetes Care 26, 314\u2013319 (2003).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1212\/01.WNL.0000134666.64593.BA","volume":"63","author":"K Yaffe","year":"2004","unstructured":"Yaffe, K. et al. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63, 658\u2013663 (2004).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR19","first-page":"287","volume":"10","author":"Z Arvanitakis","year":"2006","unstructured":"Arvanitakis, Z., Wilson, R. S. & Bennett, D. A. Diabetes mellitus, dementia, and cognitive function in older persons. J. Nutr. Health Aging 10, 287\u2013291 (2006).","journal-title":"J. Nutr. Health Aging"},{"key":"BFnrneurol2017185_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00125-009-1314-y","volume":"52","author":"JC Henquin","year":"2009","unstructured":"Henquin, J. C. Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia 52, 739\u2013751 (2009).","journal-title":"Diabetologia"},{"issue":"Suppl. 1","key":"BFnrneurol2017185_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/dom.12729","volume":"18","author":"M Wortham","year":"2016","unstructured":"Wortham, M. & Sander, M. Mechanisms of \u03b2-cell functional adaptation to changes in workload. Diabetes Obes. Metab. 18 (Suppl. 1), 78\u201386 (2016).","journal-title":"Diabetes Obes. Metab."},{"key":"BFnrneurol2017185_CR22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/dneu.20778","volume":"70","author":"I Torres-Aleman","year":"2010","unstructured":"Torres-Aleman, I. Toward a comprehensive neurobiology of IGF-I. Dev. Neurobiol. 70, 384\u2013396 (2010).","journal-title":"Dev. Neurobiol."},{"key":"BFnrneurol2017185_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2016.03.056","volume":"325","author":"AH Dyer","year":"2016","unstructured":"Dyer, A. H., Vahdatpour, C., Sanfeliu, A. & Tropea, D. The role of Insulin-Like Growth Factor 1 (IGF-1) in brain development, maturation and neuroplasticity. Neuroscience 325, 89\u201399 (2016).","journal-title":"Neuroscience"},{"key":"BFnrneurol2017185_CR24","unstructured":"De Meyts, P. The insulin receptor and its signal transduction network. Endotext https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK378978\/ (2000)."},{"key":"BFnrneurol2017185_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cmet.2007.03.001","volume":"5","author":"H Sano","year":"2007","unstructured":"Sano, H. et al. Rab10, a target of the AS160 Rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane. Cell Metab. 5, 293\u2013303 (2007).","journal-title":"Cell Metab."},{"key":"BFnrneurol2017185_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","volume":"4","author":"L Rui","year":"2014","unstructured":"Rui, L. Energy metabolism in the liver. Compr. Physiol. 4, 177\u2013197 (2014).","journal-title":"Compr. Physiol."},{"key":"BFnrneurol2017185_CR27","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/db16-0152","volume":"65","author":"GL King","year":"2016","unstructured":"King, G. L., Park, K. & Li, Q. Selective insulin resistance and the development of cardiovascular diseases in diabetes: the 2015 Edwin Bierman Award lecture. Diabetes 65, 1462\u20131471 (2016).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR28","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1210\/endo-127-6-3234","volume":"127","author":"JL Marks","year":"1990","unstructured":"Marks, J. L., Porte, D. Jr., Stahl, W. L. & Baskin, D. G. Localization of insulin receptor mRNA in rat brain by in situ hybridization. Endocrinology 127, 3234\u20133236 (1990).","journal-title":"Endocrinology"},{"key":"BFnrneurol2017185_CR29","first-page":"1215","volume":"13","author":"JW Unger","year":"1998","unstructured":"Unger, J. W. & Betz, M. Insulin receptors and signal transduction proteins in the hypothalamo-hypophyseal system: a review on morphological findings and functional implications. Histol. Histopathol. 13, 1215\u20131224 (1998).","journal-title":"Histol. Histopathol."},{"key":"BFnrneurol2017185_CR30","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1210\/endo-121-4-1562","volume":"121","author":"GA Werther","year":"1987","unstructured":"Werther, G. A. et al. Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology 121, 1562\u20131570 (1987).","journal-title":"Endocrinology"},{"key":"BFnrneurol2017185_CR31","doi-asserted-by":"publisher","first-page":"34893","DOI":"10.1074\/jbc.274.49.34893","volume":"274","author":"W Zhao","year":"1999","unstructured":"Zhao, W. et al. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J. Biol. Chem. 274, 34893\u201334902 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2017185_CR32","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00702-010-0456-x","volume":"117","author":"S Bromander","year":"2010","unstructured":"Bromander, S. et al. Cerebrospinal fluid insulin during non-neurological surgery. J. Neural Transm. (Vienna) 117, 1167\u20131170 (2010).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"BFnrneurol2017185_CR33","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1210\/jcem-64-1-190","volume":"64","author":"BJ Wallum","year":"1987","unstructured":"Wallum, B. J. et al. Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J. Clin. Endocrinol. Metab. 64, 190\u2013194 (1987).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneurol2017185_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejphar.2004.02.040","volume":"490","author":"WA Banks","year":"2004","unstructured":"Banks, W. A. The source of cerebral insulin. Eur. J. Pharmacol. 490, 5\u201312 (2004).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrneurol2017185_CR35","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1172\/JCI116773","volume":"92","author":"GD Baura","year":"1993","unstructured":"Baura, G. D. et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J. Clin. Invest. 92, 1824\u20131830 (1993).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017185_CR36","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0196-9781(97)00231-3","volume":"18","author":"WA Banks","year":"1997","unstructured":"Banks, W. A., Jaspan, J. B., Huang, W. & Kastin, A. J. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 18, 1423\u20131429 (1997).","journal-title":"Peptides"},{"key":"BFnrneurol2017185_CR37","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1111\/j.1471-4159.1985.tb07167.x","volume":"44","author":"WM Pardridge","year":"1985","unstructured":"Pardridge, W. M., Eisenberg, J. & Yang, J. Human blood-brain barrier insulin receptor. J. Neurochem. 44, 1771\u20131778 (1985).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2017185_CR38","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/JCI115431","volume":"88","author":"MW Schwartz","year":"1991","unstructured":"Schwartz, M. W. et al. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J. Clin. Invest. 88, 1272\u20131281 (1991).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017185_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","volume":"136","author":"WA Banks","year":"2012","unstructured":"Banks, W. A., Owen, J. B. & Erickson, M. A. Insulin in the brain: there and back again. Pharmacol. Ther. 136, 82\u201393 (2012).","journal-title":"Pharmacol. Ther."},{"key":"BFnrneurol2017185_CR40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00592-013-0546-y","volume":"51","author":"M Heni","year":"2014","unstructured":"Heni, M. et al. Evidence for altered transport of insulin across the blood-brain barrier in insulin-resistant humans. Acta Diabetol. 51, 679\u2013681 (2014).","journal-title":"Acta Diabetol."},{"key":"BFnrneurol2017185_CR41","doi-asserted-by":"publisher","first-page":"e0126804","DOI":"10.1371\/journal.pone.0126804","volume":"10","author":"T Sartorius","year":"2015","unstructured":"Sartorius, T. et al. The brain response to peripheral insulin declines with age: a contribution of the blood-brain barrier? PLOS ONE 10, e0126804 (2015).","journal-title":"PLOS ONE"},{"key":"BFnrneurol2017185_CR42","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1084\/jem.20160493","volume":"213","author":"M Stanley","year":"2016","unstructured":"Stanley, M., Macauley, S. L. & Holtzman, D. M. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence? J. Exp. Med. 213, 1375\u20131385 (2016).","journal-title":"J. Exp. Med."},{"key":"BFnrneurol2017185_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/BF00283141","volume":"28","author":"SJ Giddings","year":"1985","unstructured":"Giddings, S. J., Chirgwin, J. & Permutt, M. A. Evaluation of rat insulin messenger RNA in pancreatic and extrapancreatic tissues. Diabetologia 28, 343\u2013347 (1985).","journal-title":"Diabetologia"},{"key":"BFnrneurol2017185_CR44","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1471-4159.1986.tb00686.x","volume":"47","author":"DW Clarke","year":"1986","unstructured":"Clarke, D. W. et al. Insulin is released from rat brain neuronal cells in culture. J. Neurochem. 47, 831\u2013836 (1986).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2017185_CR45","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0143-4179(86)90035-1","volume":"8","author":"WS Young III.","year":"1986","unstructured":"Young, W. S. III. Periventricular hypothalamic cells in the rat brain contain insulin mRNA. Neuropeptides 8, 93\u201397 (1986).","journal-title":"Neuropeptides"},{"key":"BFnrneurol2017185_CR46","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1016\/S0021-9258(17)37214-9","volume":"269","author":"SU Devaskar","year":"1994","unstructured":"Devaskar, S. U. et al. Insulin gene expression and insulin synthesis in mammalian neuronal cells. J. Biol. Chem. 269, 8445\u20138454 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2017185_CR47","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1073\/pnas.90.2.527","volume":"90","author":"L Deltour","year":"1993","unstructured":"Deltour, L. et al. Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. Proc. Natl Acad. Sci. USA 90, 527\u2013531 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017185_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0006-8993(92)90313-X","volume":"582","author":"R Schechter","year":"1992","unstructured":"Schechter, R. et al. Developmental regulation of insulin in the mammalian central nervous system. Brain Res. 582, 27\u201337 (1992).","journal-title":"Brain Res."},{"key":"BFnrneurol2017185_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF02935589","volume":"3","author":"M Adamo","year":"1989","unstructured":"Adamo, M., Raizada, M. K. & LeRoith, D. Insulin and insulin-like growth factor receptors in the nervous system. Mol. Neurobiol. 3, 71\u2013100 (1989).","journal-title":"Mol. Neurobiol."},{"key":"BFnrneurol2017185_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0169-328X(90)90052-F","volume":"8","author":"GT Coker III","year":"1990","unstructured":"Coker, G. T. III, Studelska, D., Harmon, S., Burke, W. & O'Malley, K. L. Analysis of tyrosine hydroxylase and insulin transcripts in human neuroendocrine tissues. Brain Res. Mol. Brain Res. 8, 93\u201398 (1990).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"BFnrneurol2017185_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0167-0115(93)90335-6","volume":"48","author":"SU Devaskar","year":"1993","unstructured":"Devaskar, S. U., Singh, B. S., Carnaghi, L. R., Rajakumar, P. A. & Giddings, S. J. Insulin II gene expression in rat central nervous system. Regul. Pept. 48, 55\u201363 (1993).","journal-title":"Regul. Pept."},{"key":"BFnrneurol2017185_CR52","doi-asserted-by":"publisher","first-page":"795","DOI":"10.2174\/1381612033455323","volume":"9","author":"SC Woods","year":"2003","unstructured":"Woods, S. C., Seeley, R. J., Baskin, D. G. & Schwartz, M. W. Insulin and the blood-brain barrier. Curr. Pharm. Des. 9, 795\u2013800 (2003).","journal-title":"Curr. Pharm. Des."},{"key":"BFnrneurol2017185_CR53","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0065-1281(82)80080-9","volume":"70","author":"A Dorn","year":"1982","unstructured":"Dorn, A., Rinne, A., Hahn, H. J., Bernstein, H. G. & Ziegler, M. C-Peptide immunoreactive neurons in human brain. Acta Histochem. 70, 326\u2013330 (1982).","journal-title":"Acta Histochem."},{"key":"BFnrneurol2017185_CR54","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s007020050068","volume":"105","author":"L Frolich","year":"1998","unstructured":"Frolich, L. et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J. Neural Transm. (Vienna) 105, 423\u2013438 (1998).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"BFnrneurol2017185_CR55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-2005-7107","volume":"7","author":"E Steen","year":"2005","unstructured":"Steen, E. et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease \u2014 is this type 3 diabetes? J. Alzheimers Dis. 7, 63\u201380 (2005).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2017185_CR56","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.cmet.2012.10.019","volume":"16","author":"AE Mehran","year":"2012","unstructured":"Mehran, A. E. et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab. 16, 723\u2013737 (2012).","journal-title":"Cell Metab."},{"key":"BFnrneurol2017185_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejphar.2008.01.051","volume":"585","author":"TJ Nelson","year":"2008","unstructured":"Nelson, T. J., Sun, M. K., Hongpaisan, J. & Alkon, D. L. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur. J. Pharmacol. 585, 76\u201387 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrneurol2017185_CR58","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.pneurobio.2006.06.003","volume":"79","author":"LP van der Heide","year":"2006","unstructured":"van der Heide, L. P., Ramakers, G. M. & Smidt, M. P. Insulin signaling in the central nervous system: learning to survive. Prog. Neurobiol. 79, 205\u2013221 (2006).","journal-title":"Prog. Neurobiol."},{"key":"BFnrneurol2017185_CR59","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2826.1989.tb00131.x","volume":"1","author":"GA Werther","year":"1989","unstructured":"Werther, G. A. et al. Localization and characterization of insulin-like growth factor-i receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry* A distinct distribution from insulin receptors. J. Neuroendocrinol. 1, 369\u2013377 (1989).","journal-title":"J. Neuroendocrinol."},{"key":"BFnrneurol2017185_CR60","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.neuroscience.2006.07.055","volume":"143","author":"JG Mielke","year":"2006","unstructured":"Mielke, J. G., Taghibiglou, C. & Wang, Y. T. Endogenous insulin signaling protects cultured neurons from oxygen-glucose deprivation-induced cell death. Neuroscience 143, 165\u2013173 (2006).","journal-title":"Neuroscience"},{"key":"BFnrneurol2017185_CR61","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1523\/JNEUROSCI.19-17-07300.1999","volume":"19","author":"MA Abbott","year":"1999","unstructured":"Abbott, M. A., Wells, D. G. & Fallon, J. R. The insulin receptor tyrosine kinase substrate p58\/53 and the insulin receptor are components of CNS synapses. J. Neurosci. 19, 7300\u20137308 (1999).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2017185_CR62","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1046\/j.1471-4159.2002.01204.x","volume":"83","author":"J Bockmann","year":"2002","unstructured":"Bockmann, J., Kreutz, M. R., Gundelfinger, E. D. & Bockers, T. M. ProSAP\/Shank postsynaptic density proteins interact with insulin receptor tyrosine kinase substrate IRSp53. J. Neurochem. 83, 1013\u20131017 (2002).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2017185_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/B978-0-12-385506-0.00004-1","volume":"98","author":"JG Mielke","year":"2011","unstructured":"Mielke, J. G. & Wang, Y. T. Insulin, synaptic function, and opportunities for neuroprotection. Prog. Mol. Biol. Transl Sci. 98, 133\u2013186 (2011).","journal-title":"Prog. Mol. Biol. Transl Sci."},{"key":"BFnrneurol2017185_CR64","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/jnc.13909","volume":"140","author":"M Gralle","year":"2017","unstructured":"Gralle, M. The neuronal insulin receptor in its environment. J. Neurochem. 140, 359\u2013367 (2017).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2017185_CR65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cobeha.2015.12.004","volume":"9","author":"JR Fadel","year":"2016","unstructured":"Fadel, J. R. & Reagan, L. P. Stop signs in hippocampal insulin signaling: the role of insulin resistance in structural, functional and behavioral deficits. Curr. Opin. Behav. Sci. 9, 47\u201354 (2016).","journal-title":"Curr. Opin. Behav. Sci."},{"key":"BFnrneurol2017185_CR66","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1172\/JCI64595","volume":"123","author":"FG De Felice","year":"2013","unstructured":"De Felice, F. G. Alzheimer's disease and insulin resistance: translating basic science into clinical applications. J. Clin. Invest. 123, 531\u2013539 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017185_CR67","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/j.1471-4159.2005.03269.x","volume":"94","author":"LP van der Heide","year":"2005","unstructured":"van der Heide, L. P., Kamal, A., Artola, A., Gispen, W. H. & Ramakers, G. M. Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-D-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J. Neurochem. 94, 1158\u20131166 (2005).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2017185_CR68","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.neuron.2008.04.014","volume":"58","author":"SL Chiu","year":"2008","unstructured":"Chiu, S. L., Chen, C. M. & Cline, H. T. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 58, 708\u2013719 (2008).","journal-title":"Neuron"},{"key":"BFnrneurol2017185_CR69","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.neuropharm.2011.06.003","volume":"61","author":"CC Lee","year":"2011","unstructured":"Lee, C. C., Huang, C. C. & Hsu, K. S. Insulin promotes dendritic spine and synapse formation by the PI3K\/Akt\/mTOR and Rac1 signaling pathways. Neuropharmacology 61, 867\u2013879 (2011).","journal-title":"Neuropharmacology"},{"key":"BFnrneurol2017185_CR70","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuron.2007.01.029","volume":"53","author":"S Peineau","year":"2007","unstructured":"Peineau, S. et al. LTP inhibits LTD in the hippocampus via regulation of GSK3\u03b2. Neuron 53, 703\u2013717 (2007).","journal-title":"Neuron"},{"key":"BFnrneurol2017185_CR71","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00702-004-0163-6","volume":"112","author":"SJ Kim","year":"2005","unstructured":"Kim, S. J. & Han, Y. Insulin inhibits AMPA-induced neuronal damage via stimulation of protein kinase B (Akt). J. Neural Transm. (Vienna) 112, 179\u2013191 (2005).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"BFnrneurol2017185_CR72","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/jnr.490220405","volume":"22","author":"KA Heidenrich","year":"1989","unstructured":"Heidenrich, K. A., Gilmore, P. R. & Garvey, W. T. Glucose transport in primary cultured neurons. J. Neurosci. Res. 22, 397\u2013407 (1989).","journal-title":"J. Neurosci. Res."},{"key":"BFnrneurol2017185_CR73","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.expneurol.2005.10.035","volume":"198","author":"E Uemura","year":"2006","unstructured":"Uemura, E. & Greenlee, H. W. Insulin regulates neuronal glucose uptake by promoting translocation of glucose transporter GLUT3. Exp. Neurol. 198, 48\u201353 (2006).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol2017185_CR74","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4149\/endo_2014_01_35","volume":"48","author":"J Jurcovicova","year":"2014","unstructured":"Jurcovicova, J. Glucose transport in brain - effect of inflammation. Endocr. Regul. 48, 35\u201348 (2014).","journal-title":"Endocr. Regul."},{"key":"BFnrneurol2017185_CR75","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot, K. et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316\u20131338 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017185_CR76","first-page":"71","volume":"16","author":"R Duelli","year":"2001","unstructured":"Duelli, R. & Kuschinsky, W. Brain glucose transporters: relationship to local energy demand. News Physiol. Sci. 16, 71\u201376 (2001).","journal-title":"News Physiol. Sci."},{"key":"BFnrneurol2017185_CR77","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/(SICI)1097-4547(19990901)57:5<693::AID-JNR11>3.0.CO;2-X","volume":"57","author":"J Apelt","year":"1999","unstructured":"Apelt, J., Mehlhorn, G. & Schliebs, R. Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain. J. Neurosci. Res. 57, 693\u2013705 (1999).","journal-title":"J. Neurosci. Res."},{"key":"BFnrneurol2017185_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejphar.2004.02.041","volume":"490","author":"BS McEwen","year":"2004","unstructured":"McEwen, B. S. & Reagan, L. P. Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur. J. Pharmacol. 490, 13\u201324 (2004).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrneurol2017185_CR79","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.brainres.2009.08.005","volume":"1296","author":"CA Grillo","year":"2009","unstructured":"Grillo, C. A., Piroli, G. G., Hendry, R. M. & Reagan, L. P. Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res. 1296, 35\u201345 (2009).","journal-title":"Brain Res."},{"key":"BFnrneurol2017185_CR80","doi-asserted-by":"publisher","first-page":"11851","DOI":"10.1523\/JNEUROSCI.1700-16.2016","volume":"36","author":"J Pearson-Leary","year":"2016","unstructured":"Pearson-Leary, J. & McNay, E. C. Novel roles for the insulin-regulated glucose transporter-4 in hippocampally dependent memory. J. Neurosci. 36, 11851\u201311864 (2016).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2017185_CR81","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainres.2005.04.079","volume":"1049","author":"T Komori","year":"2005","unstructured":"Komori, T. et al. Subcellular localization of glucose transporter 4 in the hypothalamic arcuate nucleus of ob\/ob mice under basal conditions. Brain Res. 1049, 34\u201342 (2005).","journal-title":"Brain Res."},{"key":"BFnrneurol2017185_CR82","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/db16-0917","volume":"66","author":"CM Reno","year":"2017","unstructured":"Reno, C. M. et al. Brain GLUT4 knockout mice have impaired glucose tolerance, decreased insulin sensitivity, and impaired hypoglycemic counterregulation. Diabetes 66, 587\u2013597 (2017).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR83","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.neurobiolaging.2007.04.013","volume":"29","author":"DP Pelvig","year":"2008","unstructured":"Pelvig, D. P., Pakkenberg, H., Stark, A. K. & Pakkenberg, B. Neocortical glial cell numbers in human brains. Neurobiol. Aging 29, 1754\u20131762 (2008).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2017185_CR84","first-page":"237","volume-title":"The Human Brain in Figures and tables","author":"S Blinkow","year":"1968","unstructured":"Blinkow, S. & Glezer, I. in The Human Brain in Figures and tables (ed. Blinkow, F. G.) 237\u2013253 (Plenum Press, 1968)."},{"key":"BFnrneurol2017185_CR85","doi-asserted-by":"publisher","first-page":"6804","DOI":"10.1523\/JNEUROSCI.20-18-06804.2000","volume":"20","author":"R Wender","year":"2000","unstructured":"Wender, R. et al. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J. Neurosci. 20, 6804\u20136810 (2000).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2017185_CR86","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000017324","volume":"20","author":"L Pellerin","year":"1998","unstructured":"Pellerin, L. et al. Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev. Neurosci. 20, 291\u2013299 (1998).","journal-title":"Dev. Neurosci."},{"key":"BFnrneurol2017185_CR87","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1212\/WNL.0000000000000328","volume":"82","author":"EE Benarroch","year":"2014","unstructured":"Benarroch, E. E. Brain glucose transporters: implications for neurologic disease. Neurology 82, 1374\u20131379 (2014).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR88","doi-asserted-by":"publisher","first-page":"102054","DOI":"10.1155\/2015\/102054","volume":"2015","author":"F Berhane","year":"2015","unstructured":"Berhane, F. et al. Plasma lactate levels increase during hyperinsulinemic euglycemic clamp and oral glucose tolerance test. J. Diabetes Res. 2015, 102054 (2015).","journal-title":"J. Diabetes Res."},{"key":"BFnrneurol2017185_CR89","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/BF00965500","volume":"7","author":"J Albrecht","year":"1982","unstructured":"Albrecht, J., Wroblewska, B. & Mossakowski, M. J. The binding of insulin to cerebral capillaries and astrocytes of the rat. Neurochem. Res. 7, 489\u2013494 (1982).","journal-title":"Neurochem. Res."},{"key":"BFnrneurol2017185_CR90","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13041-015-0138-6","volume":"8","author":"CJ Garwood","year":"2015","unstructured":"Garwood, C. J. et al. Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors. Mol. Brain 8, 51 (2015).","journal-title":"Mol. Brain"},{"key":"BFnrneurol2017185_CR91","doi-asserted-by":"publisher","first-page":"684","DOI":"10.2174\/1567205012666150710104428","volume":"12","author":"LJ Spielman","year":"2015","unstructured":"Spielman, L. J., Bahniwal, M., Little, J. P., Walker, D. G. & Klegeris, A. Insulin modulates in vitro secretion of cytokines and cytotoxins by human glial cells. Curr. Alzheimer Res. 12, 684\u2013693 (2015).","journal-title":"Curr. Alzheimer Res."},{"key":"BFnrneurol2017185_CR92","doi-asserted-by":"publisher","first-page":"e21594","DOI":"10.1371\/journal.pone.0021594","volume":"6","author":"M Heni","year":"2011","unstructured":"Heni, M. et al. Insulin promotes glycogen storage and cell proliferation in primary human astrocytes. PLoS ONE 6, e21594 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrneurol2017185_CR93","doi-asserted-by":"crossref","first-page":"11672","DOI":"10.1016\/S0021-9258(20)71260-3","volume":"259","author":"DW Clarke","year":"1984","unstructured":"Clarke, D. W., Boyd, F. T. Jr., Kappy, M. S. & Raizada, M. K. Insulin binds to specific receptors and stimulates 2-deoxy-D-glucose uptake in cultured glial cells from rat brain. J. Biol. Chem. 259, 11672\u201311675 (1984).","journal-title":"J. Biol. Chem."},{"key":"BFnrneurol2017185_CR94","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0165-3806(02)00355-3","volume":"136","author":"P Ye","year":"2002","unstructured":"Ye, P., Li, L., Lund, P. K. & D'Ercole, A. J. Deficient expression of insulin receptor substrate-1 (IRS-1) fails to block insulin-like growth factor-I (IGF-I) stimulation of brain growth and myelination. Brain Res. Dev. Brain Res. 136, 111\u2013121 (2002).","journal-title":"Brain Res. Dev. Brain Res."},{"key":"BFnrneurol2017185_CR95","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/NEN.0b013e3181ef3be4","volume":"69","author":"QL Cui","year":"2010","unstructured":"Cui, Q. L. et al. Response of human oligodendrocyte progenitors to growth factors and axon signals. J. Neuropathol. Exp. Neurol. 69, 930\u2013944 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol2017185_CR96","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11481-016-9708-3","volume":"12","author":"MK Mamik","year":"2017","unstructured":"Mamik, M. K. et al. HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation. J. Neuroimmune Pharmacol. 12, 233\u2013248 (2017).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"BFnrneurol2017185_CR97","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.brainres.2006.06.109","volume":"1112","author":"AW Pardini","year":"2006","unstructured":"Pardini, A. W. et al. Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis. Brain Res. 1112, 169\u2013178 (2006).","journal-title":"Brain Res."},{"key":"BFnrneurol2017185_CR98","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1152\/ajplegacy.1970.219.4.938","volume":"219","author":"AF Debons","year":"1970","unstructured":"Debons, A. F., Krimsky, I. & From, A. A direct action of insulin on the hypothalamic satiety center. Am. J. Physiol. 219, 938\u2013943 (1970).","journal-title":"Am. J. Physiol."},{"key":"BFnrneurol2017185_CR99","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0091-3057(74)90056-2","volume":"2","author":"JS Hatfield","year":"1974","unstructured":"Hatfield, J. S., Millard, W. J. & Smith, C. J. Short-term influence of intra-ventromedial hypothalamic administration of insulin on feeding in normal and diabetic rats. Pharmacol. Biochem. Behav. 2, 223\u2013226 (1974).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BFnrneurol2017185_CR100","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0031-9384(77)90343-2","volume":"19","author":"JH Strubbe","year":"1977","unstructured":"Strubbe, J. H. & Mein, C. G. Increased feeding in response to bilateral injection of insulin antibodies in the VMH. Physiol. Behav. 19, 309\u2013313 (1977).","journal-title":"Physiol. Behav."},{"key":"BFnrneurol2017185_CR101","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/B978-0-12-027310-2.50024-4","volume":"10","author":"SC Woods","year":"1983","unstructured":"Woods, S. C. & Porte, D. Jr. The role of insulin as a satiety factor in the central nervous system. Adv. Metab. Disord. 10, 457\u2013468 (1983).","journal-title":"Adv. Metab. Disord."},{"key":"BFnrneurol2017185_CR102","first-page":"387","volume":"13","author":"MW Schwartz","year":"1992","unstructured":"Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C. & Porte, D. Jr. Insulin in the brain: a hormonal regulator of energy balance. Endocr. Rev. 13, 387\u2013414 (1992).","journal-title":"Endocr. Rev."},{"key":"BFnrneurol2017185_CR103","first-page":"607","volume":"75","author":"B Ajaya","year":"1982","unstructured":"Ajaya, B. & Haranath, P. S. Effects of insulin administered into cerebrospinal fluid spaces on blood glucose in unanaesthetized and anaesthetized dogs. Indian J. Med. Res. 75, 607\u2013615 (1982).","journal-title":"Indian J. Med. Res."},{"key":"BFnrneurol2017185_CR104","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0091-3057(01)00780-8","volume":"72","author":"EL Air","year":"2002","unstructured":"Air, E. L., Benoit, S. C., Blake Smith, K. A., Clegg, D. J. & Woods, S. C. Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacol. Biochem. Behav. 72, 423\u2013429 (2002).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BFnrneurol2017185_CR105","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/282503a0","volume":"282","author":"SC Woods","year":"1979","unstructured":"Woods, S. C., Lotter, E. C., McKay, L. D. & Porte, D. Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282, 503\u2013505 (1979).","journal-title":"Nature"},{"key":"BFnrneurol2017185_CR106","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1152\/ajpregu.90736.2008","volume":"298","author":"L Jessen","year":"2010","unstructured":"Jessen, L., Clegg, D. J. & Bouman, S. D. Evaluation of the lack of anorectic effect of intracerebroventricular insulin in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R43\u2013R50 (2010).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrneurol2017185_CR107","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nature03439","volume":"434","author":"A Pocai","year":"2005","unstructured":"Pocai, A. et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434, 1026\u20131031 (2005).","journal-title":"Nature"},{"key":"BFnrneurol2017185_CR108","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nn0602-861","volume":"5","author":"S Obici","year":"2002","unstructured":"Obici, S., Feng, Z., Karkanias, G., Baskin, D. G. & Rossetti, L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat. Neurosci. 5, 566\u2013572 (2002).","journal-title":"Nat. Neurosci."},{"key":"BFnrneurol2017185_CR109","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/nm1202-798","volume":"8","author":"S Obici","year":"2002","unstructured":"Obici, S., Zhang, B. B., Karkanias, G. & Rossetti, L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat. Med. 8, 1376\u20131382 (2002).","journal-title":"Nat. Med."},{"key":"BFnrneurol2017185_CR110","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2011.01.008","volume":"13","author":"T Scherer","year":"2011","unstructured":"Scherer, T. et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab. 13, 183\u2013194 (2011).","journal-title":"Cell Metab."},{"key":"BFnrneurol2017185_CR111","doi-asserted-by":"publisher","first-page":"E246","DOI":"10.1210\/jc.2013-3169","volume":"99","author":"KA Iwen","year":"2014","unstructured":"Iwen, K. A. et al. Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans. J. Clin. Endocrinol. Metab. 99, E246\u2013E251 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneurol2017185_CR112","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.cmet.2014.09.003","volume":"20","author":"AC Shin","year":"2014","unstructured":"Shin, A. C. et al. Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. Cell Metab. 20, 898\u2013909 (2014).","journal-title":"Cell Metab."},{"key":"BFnrneurol2017185_CR113","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jalz.2016.01.008","volume":"12","author":"HH Ruiz","year":"2016","unstructured":"Ruiz, H. H. et al. Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels. Alzheimers Dement. 12, 851\u2013861 (2016).","journal-title":"Alzheimers Dement."},{"key":"BFnrneurol2017185_CR114","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1210\/jc.2007-2606","volume":"93","author":"C Benedict","year":"2008","unstructured":"Benedict, C., Kern, W., Schultes, B., Born, J. & Hallschmid, M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J. Clin. Endocrinol. Metab. 93, 1339\u20131344 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneurol2017185_CR115","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/sj.ijo.0803722","volume":"32","author":"M Hallschmid","year":"2008","unstructured":"Hallschmid, M., Benedict, C., Schultes, B., Born, J. & Kern, W. Obese men respond to cognitive but not to catabolic brain insulin signaling. Int. J. Obes. (Lond.) 32, 275\u2013282 (2008).","journal-title":"Int. J. Obes. (Lond.)"},{"key":"BFnrneurol2017185_CR116","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","volume":"29","author":"C Benedict","year":"2004","unstructured":"Benedict, C. et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology 29, 1326\u20131334 (2004).","journal-title":"Psychoneuroendocrinology"},{"key":"BFnrneurol2017185_CR117","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1210\/jc.2014-3018","volume":"100","author":"YF Brunner","year":"2015","unstructured":"Brunner, Y. F., Kofoet, A., Benedict, C. & Freiherr, J. Central insulin administration improves odor-cued reactivation of spatial memory in young men. J. Clin. Endocrinol. Metab. 100, 212\u2013219 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneurol2017185_CR118","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2337\/dc13-1672","volume":"37","author":"V Novak","year":"2014","unstructured":"Novak, V. et al. Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Diabetes Care 37, 751\u2013759 (2014).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR119","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","volume":"27","author":"MA Reger","year":"2006","unstructured":"Reger, M. A. et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol. Aging 27, 451\u2013458 (2006).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2017185_CR120","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"S Craft","year":"2012","unstructured":"Craft, S. et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch. Neurol. 69, 29\u201338 (2012).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2017185_CR121","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3233\/JAD-159002","volume":"45","author":"A Claxton","year":"2015","unstructured":"Claxton, A. et al. Long acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage alzheimer's disease dementia. J. Alzheimers Dis. 45, 1269\u20131270 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2017185_CR122","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3233\/JAD-2008-13309","volume":"13","author":"MA Reger","year":"2008","unstructured":"Reger, M. A. et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-\u03b2 in memory-impaired older adults. J. Alzheimers Dis. 13, 323\u2013331 (2008).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2017185_CR123","doi-asserted-by":"publisher","first-page":"E468","DOI":"10.1210\/jc.2010-0744","volume":"95","author":"R Krug","year":"2010","unstructured":"Krug, R., Benedict, C., Born, J. & Hallschmid, M. Comparable sensitivity of postmenopausal and young women to the effects of intranasal insulin on food intake and working memory. J. Clin. Endocrinol. Metab. 95, E468\u2013E472 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneurol2017185_CR124","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1210\/jc.2009-1677","volume":"95","author":"M Guthoff","year":"2010","unstructured":"Guthoff, M. et al. Insulin modulates food-related activity in the central nervous system. J. Clin. Endocrinol. Metab. 95, 748\u2013755 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneurol2017185_CR125","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2337\/db14-1000","volume":"64","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes 64, 1025\u20131034 (2015).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR126","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/hbm.22304","volume":"35","author":"TM Schilling","year":"2014","unstructured":"Schilling, T. M. et al. Intranasal insulin increases regional cerebral blood flow in the insular cortex in men independently of cortisol manipulation. Hum. Brain Mapp. 35, 1944\u20131956 (2014).","journal-title":"Hum. Brain Mapp."},{"key":"BFnrneurol2017185_CR127","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2337\/diabetes.48.3.557","volume":"48","author":"W Kern","year":"1999","unstructured":"Kern, W., Born, J., Schreiber, H. & Fehm, H. L. Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes 48, 557\u2013563 (1999).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR128","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.2337\/diabetes.53.9.2202","volume":"53","author":"M Hallschmid","year":"2004","unstructured":"Hallschmid, M. et al. Transcortical direct current potential shift reflects immediate signaling of systemic insulin to the human brain. Diabetes 53, 2202\u20132208 (2004).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR129","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fnsys.2010.00157","volume":"4","author":"KT Stingl","year":"2010","unstructured":"Stingl, K. T. et al. Insulin modulation of magnetoencephalographic resting state dynamics in lean and obese subjects. Front. Syst. Neurosci. 4, 157 (2010).","journal-title":"Front. Syst. Neurosci."},{"key":"BFnrneurol2017185_CR130","doi-asserted-by":"publisher","first-page":"12103","DOI":"10.1073\/pnas.0604404103","volume":"103","author":"O Tschritter","year":"2006","unstructured":"Tschritter, O. et al. The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. Proc. Natl Acad. Sci. USA 103, 12103\u201312108 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017185_CR131","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1749-6632.2000.tb06371.x","volume":"903","author":"S Craft","year":"2000","unstructured":"Craft, S. et al. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann. NY Acad. Sci. 903, 222\u2013228 (2000).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrneurol2017185_CR132","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.physbeh.2010.01.004","volume":"100","author":"EC McNay","year":"2010","unstructured":"McNay, E. C. & Cotero, V. E. Mini-review: impact of recurrent hypoglycemia on cognitive and brain function. Physiol. Behav. 100, 234\u2013238 (2010).","journal-title":"Physiol. Behav."},{"key":"BFnrneurol2017185_CR133","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00213-015-4125-5","volume":"233","author":"B Stollery","year":"2016","unstructured":"Stollery, B. & Christian, L. Glucose improves object-location binding in visual-spatial working memory. Psychopharmacol. (Berl.) 233, 529\u2013547 (2016).","journal-title":"Psychopharmacol. (Berl.)"},{"key":"BFnrneurol2017185_CR134","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1056\/NEJMoa1215740","volume":"369","author":"PK Crane","year":"2013","unstructured":"Crane, P. K., Walker, R. & Larson, E. B. Glucose levels and risk of dementia. N. Engl. J. Med. 369, 1863\u20131864 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2017185_CR135","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1073\/pnas.050583697","volume":"97","author":"EC McNay","year":"2000","unstructured":"McNay, E. C., Fries, T. M. & Gold, P. E. Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. Proc. Natl Acad. Sci. USA 97, 2881\u20132885 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol2017185_CR136","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/1534582302238337","volume":"1","author":"EC McNay","year":"2002","unstructured":"McNay, E. C. & Gold, P. E. Food for thought: fluctuations in brain extracellular glucose provide insight into the mechanisms of memory modulation. Behav. Cogn. Neurosci. Rev. 1, 264\u2013280 (2002).","journal-title":"Behav. Cogn. Neurosci. Rev."},{"key":"BFnrneurol2017185_CR137","volume-title":"Insulin Treatment in Psychiatry","author":"M Rinkel","year":"1959","unstructured":"Rinkel, M. & Himwich, H. E. Insulin Treatment in Psychiatry (Philosophical Library, 1959)."},{"key":"BFnrneurol2017185_CR138","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.2337\/dc08-0985","volume":"31","author":"B Mezuk","year":"2008","unstructured":"Mezuk, B., Eaton, W. W., Albrecht, S. & Golden, S. H. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31, 2383\u20132390 (2008).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR139","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2337\/db09-1493","volume":"59","author":"M Hallschmid","year":"2010","unstructured":"Hallschmid, M. et al. Euglycemic infusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects. Diabetes 59, 1101\u20131107 (2010).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR140","doi-asserted-by":"publisher","first-page":"3G","DOI":"10.1016\/S0002-9149(02)02553-5","volume":"90","author":"BJ Goldstein","year":"2002","unstructured":"Goldstein, B. J. Insulin resistance as the core defect in type 2 diabetes mellitus. Am. J. Cardiol. 90, 3G\u201310G (2002).","journal-title":"Am. J. Cardiol."},{"key":"BFnrneurol2017185_CR141","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/j.1471-4159.2005.03155.x","volume":"93","author":"JG Mielke","year":"2005","unstructured":"Mielke, J. G. et al. A biochemical and functional characterization of diet-induced brain insulin resistance. J. Neurochem. 93, 1568\u20131578 (2005).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2017185_CR142","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/archinte.1922.00110120086003","volume":"30","author":"WR Miles","year":"1922","unstructured":"Miles, W. R. & Root, H. F. Psychologic tests applied in diabetic patients. Arch. Internal Med. 30, 767\u2013777 (1922).","journal-title":"Arch. Internal Med."},{"key":"BFnrneurol2017185_CR143","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/0002-9343(84)90186-4","volume":"77","author":"LC Perlmuter","year":"1984","unstructured":"Perlmuter, L. C. et al. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am. J. Med. 77, 1043\u20131048 (1984).","journal-title":"Am. J. Med."},{"key":"BFnrneurol2017185_CR144","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2337\/diacare.13.1.16","volume":"13","author":"GM Reaven","year":"1990","unstructured":"Reaven, G. M., Thompson, L. W., Nahum, D. & Haskins, E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 13, 16\u201321 (1990).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR145","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2337\/diacare.24.6.1060","volume":"24","author":"F Grodstein","year":"2001","unstructured":"Grodstein, F., Chen, J., Wilson, R. S., Manson, J. E. & Nurses' Health, S. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24, 1060\u20131065 (2001).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR146","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.2337\/dc08-2143","volume":"32","author":"C Ruis","year":"2009","unstructured":"Ruis, C. et al. Cognition in the early stage of type 2 diabetes. Diabetes Care 32, 1261\u20131265 (2009).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR147","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2337\/diabetes.55.04.06.db05-1323","volume":"55","author":"SM Manschot","year":"2006","unstructured":"Manschot, S. M. et al. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55, 1106\u20131113 (2006).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR148","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.diabres.2008.08.020","volume":"82","author":"SA Ebady","year":"2008","unstructured":"Ebady, S. A., Arami, M. A. & Shafigh, M. H. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res. Clin. Pract. 82, 305\u2013309 (2008).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFnrneurol2017185_CR149","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.2337\/db10-0752","volume":"59","author":"J Ding","year":"2010","unstructured":"Ding, J. et al. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 59, 2883\u20132889 (2010).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR150","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1212\/WNL.56.12.1683","volume":"56","author":"M Kivipelto","year":"2001","unstructured":"Kivipelto, M. et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 56, 1683\u20131689 (2001).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR151","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1001\/jama.292.18.2237","volume":"292","author":"K Yaffe","year":"2004","unstructured":"Yaffe, K. et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292, 2237\u20132242 (2004).","journal-title":"JAMA"},{"key":"BFnrneurol2017185_CR152","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/archneur.58.4.643","volume":"58","author":"C DeCarli","year":"2001","unstructured":"DeCarli, C. et al. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch. Neurol. 58, 643\u2013647 (2001).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2017185_CR153","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2337\/diacare.20.3.438","volume":"20","author":"MW Strachan","year":"1997","unstructured":"Strachan, M. W., Deary, I. J., Ewing, F. M. & Frier, B. M. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20, 438\u2013445 (1997).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR154","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1464-5491.1999.00027.x","volume":"16","author":"R Stewart","year":"1999","unstructured":"Stewart, R. & Liolitsa, D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med. 16, 93\u2013112 (1999).","journal-title":"Diabet Med."},{"key":"BFnrneurol2017185_CR155","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1007\/s00125-010-1857-y","volume":"53","author":"PL Yau","year":"2010","unstructured":"Yau, P. L. et al. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia 53, 2298\u20132306 (2010).","journal-title":"Diabetologia"},{"key":"BFnrneurol2017185_CR156","doi-asserted-by":"publisher","first-page":"e856","DOI":"10.1542\/peds.2012-0324","volume":"130","author":"PL Yau","year":"2012","unstructured":"Yau, P. L., Castro, M. G., Tagani, A., Tsui, W. H. & Convit, A. Obesity and metabolic syndrome and functional and structural brain impairments in adolescence. Pediatrics 130, e856\u2013e864 (2012).","journal-title":"Pediatrics"},{"key":"BFnrneurol2017185_CR157","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1210\/jc.2015-2318","volume":"101","author":"DA Rees","year":"2016","unstructured":"Rees, D. A., Udiawar, M., Berlot, R., Jones, D. K. & O'Sullivan, M. J. White matter microstructure and cognitive function in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 101, 314\u2013323 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrneurol2017185_CR158","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1212\/WNL.0000000000001655","volume":"84","author":"G Weinstein","year":"2015","unstructured":"Weinstein, G. et al. Glucose indices are associated with cognitive and structural brain measures in young adults. Neurology 84, 2329\u20132337 (2015).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR159","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.euroneuro.2014.01.023","volume":"24","author":"M Brundel","year":"2014","unstructured":"Brundel, M., Kappelle, L. J. & Biessels, G. J. Brain imaging in type 2 diabetes. Eur. Neuropsychopharmacol. 24, 1967\u20131981 (2014).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"BFnrneurol2017185_CR160","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/ane.12398","volume":"132","author":"A Del Bene","year":"2015","unstructured":"Del Bene, A. et al. Is type 2 diabetes related to leukoaraiosis? an updated review. Acta Neurol. Scand. 132, 147\u2013155 (2015).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol2017185_CR161","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/archneurol.2010.225","volume":"68","author":"LD Baker","year":"2011","unstructured":"Baker, L. D. et al. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch. Neurol. 68, 51\u201357 (2011).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2017185_CR162","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jamaneurol.2015.0613","volume":"72","author":"AA Willette","year":"2015","unstructured":"Willette, A. A. et al. Association of insulin resistance with cerebral glucose uptake in late middle-aged adults at risk for alzheimer disease. JAMA Neurol. 72, 1013\u20131020 (2015).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol2017185_CR163","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2967\/jnumed.113.132647","volume":"55","author":"RO Roberts","year":"2014","unstructured":"Roberts, R. O. et al. Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation. J. Nucl. Med. 55, 759\u2013764 (2014).","journal-title":"J. Nucl. Med."},{"key":"BFnrneurol2017185_CR164","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.74.1.70","volume":"74","author":"JM Starr","year":"2003","unstructured":"Starr, J. M. et al. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry 74, 70\u201376 (2003).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2017185_CR165","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1292\/jvms.15-0589","volume":"78","author":"DY Yoo","year":"2016","unstructured":"Yoo, D. Y. et al. Chronic type 2 diabetes reduces the integrity of the blood-brain barrier by reducing tight junction proteins in the hippocampus. J. Vet. Med. Sci. 78, 957\u2013962 (2016).","journal-title":"J. Vet. Med. Sci."},{"key":"BFnrneurol2017185_CR166","first-page":"125","volume":"2","author":"S Prasad","year":"2014","unstructured":"Prasad, S., Sajja, R. K., Naik, P. & Cucullo, L. Diabetes mellitus and blood-brain barrier dysfunction: an overview. J. Pharmacovigil. 2, 125 (2014).","journal-title":"J. Pharmacovigil."},{"key":"BFnrneurol2017185_CR167","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.nbd.2014.03.011","volume":"67","author":"SE Arnold","year":"2014","unstructured":"Arnold, S. E. et al. High fat diet produces brain insulin resistance, synaptodendritic abnormalities and altered behavior in mice. Neurobiol. Dis. 67, 79\u201387 (2014).","journal-title":"Neurobiol. Dis."},{"key":"BFnrneurol2017185_CR168","doi-asserted-by":"publisher","first-page":"e0128274","DOI":"10.1371\/journal.pone.0128274","volume":"10","author":"Z Liu","year":"2015","unstructured":"Liu, Z. et al. High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity. PLoSONE 10, e0128274 (2015).","journal-title":"PLoSONE"},{"key":"BFnrneurol2017185_CR169","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3233\/JAD-160640","volume":"55","author":"IV Martins","year":"2017","unstructured":"Martins, I. V., Rivers-Auty, J., Allan, S. M. & Lawrence, C. B. Mitochondrial abnormalities and synaptic loss underlie memory deficits seen in mouse models of obesity and Alzheimer's disease. J. Alzheimers Dis. 55, 915\u2013932 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2017185_CR170","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.psyneuen.2013.05.010","volume":"38","author":"JJ Ramos-Rodriguez","year":"2013","unstructured":"Ramos-Rodriguez, J. J. et al. Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice. Psychoneuroendocrinology 38, 2462\u20132475 (2013).","journal-title":"Psychoneuroendocrinology"},{"key":"BFnrneurol2017185_CR171","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.2337\/db06-0376","volume":"55","author":"K Anthony","year":"2006","unstructured":"Anthony, K. et al. Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome? Diabetes 55, 2986\u20132992 (2006).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR172","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1007\/s00125-007-0839-1","volume":"50","author":"O Tschritter","year":"2007","unstructured":"Tschritter, O. et al. Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans. Diabetologia 50, 2602\u20132603 (2007).","journal-title":"Diabetologia"},{"key":"BFnrneurol2017185_CR173","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.0954-6820.1983.tb03756.x","volume":"213","author":"G Bucht","year":"1983","unstructured":"Bucht, G., Adolfsson, R., Lithner, F. & Winblad, B. Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. ActaMed. Scand. 213, 387\u2013392 (1983).","journal-title":"ActaMed. Scand."},{"key":"BFnrneurol2017185_CR174","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jns.2011.12.008","volume":"315","author":"D Bosco","year":"2012","unstructured":"Bosco, D. et al. Dementia is associated with insulin resistance in patients with Parkinson's disease. J. Neurol. Sci. 315, 39\u201343 (2012).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol2017185_CR175","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1212\/WNL.0b013e3182553cc9","volume":"78","author":"E Cereda","year":"2012","unstructured":"Cereda, E., Barichella, M., Cassani, E., Caccialanza, R. & Pezzoli, G. Clinical features of Parkinson disease when onset of diabetes came first: a case-control study. Neurology 78, 1507\u20131511 (2012).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR176","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/mds.25211","volume":"28","author":"E Cereda","year":"2013","unstructured":"Cereda, E. et al. Diabetes and risk of Parkinson's disease. Mov Disord. 28, 257 (2013).","journal-title":"Mov Disord."},{"key":"BFnrneurol2017185_CR177","first-page":"2003","volume":"31","author":"JA Driver","year":"2008","unstructured":"Driver, J. A. et al. Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease. DiabetesCare 31, 2003\u20132005 (2008).","journal-title":"DiabetesCare"},{"key":"BFnrneurol2017185_CR178","doi-asserted-by":"publisher","first-page":"842","DOI":"10.2337\/dc06-2011","volume":"30","author":"G Hu","year":"2007","unstructured":"Hu, G., Jousilahti, P., Bidel, S., Antikainen, R. & Tuomilehto, J. Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 30, 842\u2013847 (2007).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR179","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.parkreldis.2013.01.016","volume":"19","author":"V Kotagal","year":"2013","unstructured":"Kotagal, V. et al. Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat. Disord. 19, 522\u2013526 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol2017185_CR180","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/00207459309003322","volume":"69","author":"R Sandyk","year":"1993","unstructured":"Sandyk, R. The relationship between diabetes mellitus and Parkinson's disease. Int. J. Neurosci. 69, 125\u2013130 (1993).","journal-title":"Int. J. Neurosci."},{"key":"BFnrneurol2017185_CR181","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/dc11-1511","volume":"35","author":"Y Sun","year":"2012","unstructured":"Sun, Y. et al. Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications. Diabetes Care 35, 1047\u20131049 (2012).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR182","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.parkreldis.2012.03.010","volume":"18","author":"ML Wahlqvist","year":"2012","unstructured":"Wahlqvist, M. L. et al. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort. Parkinsonism Relat. Disord. 18, 753\u2013758 (2012).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol2017185_CR183","doi-asserted-by":"publisher","first-page":"910","DOI":"10.2337\/dc10-1922","volume":"34","author":"Q Xu","year":"2011","unstructured":"Xu, Q. et al. Diabetes and risk of Parkinson's disease. Diabetes Care 34, 910\u2013915 (2011).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR184","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2047-9158-3-13","volume":"3","author":"A Golimstok","year":"2014","unstructured":"Golimstok, A. et al. Cardiovascular risk factors and frontotemporal dementia: a case-control study. Transl Neurodegener. 3, 13 (2014).","journal-title":"Transl Neurodegener."},{"key":"BFnrneurol2017185_CR185","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1212\/WNL.0b013e3181f4d7f8","volume":"75","author":"S Ahtiluoto","year":"2010","unstructured":"Ahtiluoto, S. et al. Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology 75, 1195\u20131202 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR186","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1017\/S104161020200844X","volume":"14","author":"LB Hassing","year":"2002","unstructured":"Hassing, L. B. et al. Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimer's disease: a population-based study of the oldest old. Int. Psychogeriatr. 14, 239\u2013248 (2002).","journal-title":"Int. Psychogeriatr."},{"key":"BFnrneurol2017185_CR187","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/01.wad.0000213814.43047.86","volume":"20","author":"KM Hayden","year":"2006","unstructured":"Hayden, K. M. et al. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis. Assoc. Disord. 20, 93\u2013100 (2006).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"BFnrneurol2017185_CR188","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1016\/j.archger.2010.09.004","volume":"52","author":"H Kimm","year":"2011","unstructured":"Kimm, H. et al. Mid-life and late-life vascular risk factors and dementia in Korean men and women. Arch. Gerontol. Geriatr. 52, e117\u2013e122 (2011).","journal-title":"Arch. Gerontol. Geriatr."},{"key":"BFnrneurol2017185_CR189","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","volume":"77","author":"T Ohara","year":"2011","unstructured":"Ohara, T. et al. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology 77, 1126\u20131134 (2011).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR190","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","volume":"51","author":"R Peila","year":"2002","unstructured":"Peila, R., Rodriguez, B. L., Launer, L. J. & Honolulu-Asia Aging Study. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 1256\u20131262 (2002).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR191","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1212\/WNL.58.8.1175","volume":"58","author":"HB Posner","year":"2002","unstructured":"Posner, H. B. et al. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 58, 1175\u20131181 (2002).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR192","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2337\/db08-0586","volume":"58","author":"W Xu","year":"2009","unstructured":"Xu, W. et al. Mid- and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes 58, 71\u201377 (2009).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR193","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/jdi.12087","volume":"4","author":"K Gudala","year":"2013","unstructured":"Gudala, K., Bansal, D., Schifano, F. & Bhansali, A. Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J. Diabetes Investig. 4, 640\u2013650 (2013).","journal-title":"J. Diabetes Investig."},{"key":"BFnrneurol2017185_CR194","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.2741\/e482","volume":"4","author":"SM de la Monte","year":"2012","unstructured":"de la Monte, S. M. Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease. Front. Biosci. (Elite Ed.) 4, 1582\u20131605 (2012).","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"BFnrneurol2017185_CR195","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/ijms17040503","volume":"17","author":"N Kimura","year":"2016","unstructured":"Kimura, N. Diabetes mellitus induces Alzheimer's disease pathology: histopathological evidence from animal models. Int. J. Mol. Sci. 17, 503 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"BFnrneurol2017185_CR196","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/jnc.12813","volume":"131","author":"C Rotermund","year":"2014","unstructured":"Rotermund, C., Truckenmuller, F. M., Schell, H. & Kahle, P. J. Diet-induced obesity accelerates the onset of terminal phenotypes in alpha-synuclein transgenic mice. J. Neurochem. 131, 848\u2013858 (2014).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2017185_CR197","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.2337\/dc06-1637","volume":"29","author":"B van Harten","year":"2006","unstructured":"van Harten, B., de Leeuw, F. E., Weinstein, H. C., Scheltens, P. & Biessels, G. J. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 29, 2539\u20132548 (2006).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR198","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1007\/s00125-003-1235-0","volume":"46","author":"T den Heijer","year":"2003","unstructured":"den Heijer, T. et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46, 1604\u20131610 (2003).","journal-title":"Diabetologia"},{"key":"BFnrneurol2017185_CR199","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00125-007-0602-7","volume":"50","author":"SM Gold","year":"2007","unstructured":"Gold, S. M. et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 50, 711\u2013719 (2007).","journal-title":"Diabetologia"},{"key":"BFnrneurol2017185_CR200","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2337\/dc11-2075","volume":"35","author":"C Benedict","year":"2012","unstructured":"Benedict, C. et al. Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care 35, 488\u2013494 (2012).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR201","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.2337\/dc11-0308","volume":"34","author":"ZS Tan","year":"2011","unstructured":"Tan, Z. S. et al. Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: the Framingham Offspring Study. Diabetes Care 34, 1766\u20131770 (2011).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR202","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1016\/j.neurobiolaging.2009.12.005","volume":"32","author":"NL Rasgon","year":"2011","unstructured":"Rasgon, N. L. et al. Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Neurobiol. Aging 32, 1942\u20131948 (2011).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2017185_CR203","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2337\/dc12-0922","volume":"36","author":"AA Willette","year":"2013","unstructured":"Willette, A. A. et al. Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults. Diabetes Care 36, 443\u2013449 (2013).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR204","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.jdiacomp.2016.08.012","volume":"30","author":"FC Hsu","year":"2016","unstructured":"Hsu, F. C. et al. Adiposity is inversely associated with hippocampal volume in African Americans and European Americans with diabetes. J. Diabetes Compl. 30, 1506\u20131512 (2016).","journal-title":"J. Diabetes Compl."},{"key":"BFnrneurol2017185_CR205","doi-asserted-by":"publisher","first-page":"465","DOI":"10.4103\/0366-6999.151082","volume":"128","author":"YW Zhang","year":"2015","unstructured":"Zhang, Y. W. et al. Memory dysfunction in type 2 diabetes mellitus correlates with reduced hippocampal CA1 and subiculum volumes. Chin. Med. J. (Engl.) 128, 465\u2013471 (2015).","journal-title":"Chin. Med. J. (Engl.)"},{"key":"BFnrneurol2017185_CR206","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/13803395.2013.869310","volume":"36","author":"PL Yau","year":"2014","unstructured":"Yau, P. L., Kluger, A., Borod, J. C. & Convit, A. Neural substrates of verbal memory impairments in adults with type 2 diabetes mellitus. J. Clin. Exp. Neuropsychol. 36, 74\u201387 (2014).","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"BFnrneurol2017185_CR207","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/dmrr.1230","volume":"28","author":"R Hempel","year":"2012","unstructured":"Hempel, R., Onopa, R. & Convit, A. Type 2 diabetes affects hippocampus volume differentially in men and women. Diabetes Metab. Res. Rev. 28, 76\u201383 (2012).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"BFnrneurol2017185_CR208","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1212\/WNL.0000000000001982","volume":"85","author":"C Moran","year":"2015","unstructured":"Moran, C. et al. Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology 85, 1123\u20131130 (2015).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR209","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2337\/db14-1507","volume":"64","author":"AA Willette","year":"2015","unstructured":"Willette, A. A., Modanlo, N., Kapogiannis, D. & Alzheimer's Disease Neuroimaging Initiative. Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease. Diabetes 64, 1933\u20131940 (2015).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR210","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3233\/JAD-140702","volume":"42","author":"N Garcia-Casares","year":"2014","unstructured":"Garcia-Casares, N. et al. Cognitive dysfunctions in middle-aged type 2 diabetic patients and neuroimaging correlations: a cross-sectional study. J. Alzheimers Dis. 42, 1337\u20131346 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2017185_CR211","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pscychresns.2014.01.009","volume":"222","author":"CM Marano","year":"2014","unstructured":"Marano, C. M. et al. The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging. Psychiatry Res. 222, 84\u201390 (2014).","journal-title":"Psychiatry Res."},{"key":"BFnrneurol2017185_CR212","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.neurobiolaging.2013.03.025","volume":"34","author":"M Thambisetty","year":"2013","unstructured":"Thambisetty, M. et al. Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging. Neurobiol. Aging 34, 2271\u20132276 (2013).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2017185_CR213","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jdiacomp.2012.03.021","volume":"26","author":"M Brundel","year":"2012","unstructured":"Brundel, M. et al. Cerebral haemodynamics, cognition and brain volumes in patients with type 2 diabetes. J. Diabetes Compl. 26, 205\u2013209 (2012).","journal-title":"J. Diabetes Compl."},{"key":"BFnrneurol2017185_CR214","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.2337\/db11-1669","volume":"61","author":"G Musen","year":"2012","unstructured":"Musen, G. et al. Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes 61, 2375\u20132379 (2012).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR215","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s11682-016-9583-9","volume":"11","author":"Y Cui","year":"2017","unstructured":"Cui, Y. et al. Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction. Brain Imaging Behav. 11, 1248\u20131257 (2017).","journal-title":"Brain Imaging Behav."},{"key":"BFnrneurol2017185_CR216","doi-asserted-by":"crossref","unstructured":"Hoscheidt, S. M. et al. Insulin resistance is associated with lower arterial blood flow and reduced cortical perfusion in cognitively asymptomatic middle-aged adults. J. Cereb. Blood Flow Metab. (2016).","DOI":"10.1177\/0271678X16663214"},{"key":"BFnrneurol2017185_CR217","doi-asserted-by":"publisher","first-page":"e2231","DOI":"10.1097\/MD.0000000000002231","volume":"94","author":"W Xia","year":"2015","unstructured":"Xia, W. et al. Blood pressure is associated with cerebral blood flow alterations in patients with T2DM as revealed by perfusion functional MRI. Med. (Baltimore) 94, e2231 (2015).","journal-title":"Med. (Baltimore)"},{"key":"BFnrneurol2017185_CR218","doi-asserted-by":"publisher","first-page":"11148","DOI":"10.1038\/srep11148","volume":"5","author":"W Xia","year":"2015","unstructured":"Xia, W. et al. Disrupted resting-state attentional networks in T2DM patients. Sci. Rep. 5, 11148 (2015).","journal-title":"Sci. Rep."},{"key":"BFnrneurol2017185_CR219","first-page":"719076","volume":"2015","author":"W Xia","year":"2015","unstructured":"Xia, W. et al. Insulin resistance-associated interhemispheric functional connectivity alterations in T2DM: a resting-state fMRI study. Biomed. Res. Int. 2015, 719076 (2015).","journal-title":"Biomed. Res. Int."},{"key":"BFnrneurol2017185_CR220","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1016\/j.psyneuen.2013.05.012","volume":"38","author":"W Xia","year":"2013","unstructured":"Xia, W. et al. Altered baseline brain activity in type 2 diabetes: a resting-state fMRI study. Psychoneuroendocrinology 38, 2493\u20132501 (2013).","journal-title":"Psychoneuroendocrinology"},{"key":"BFnrneurol2017185_CR221","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.jalz.2014.03.011","volume":"11","author":"AA Willette","year":"2015","unstructured":"Willette, A. A. et al. Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement. 11, 504\u2013510 (2015).","journal-title":"Alzheimers Dement."},{"key":"BFnrneurol2017185_CR222","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1001\/jamaneurol.2013.284","volume":"70","author":"M Thambisetty","year":"2013","unstructured":"Thambisetty, M. et al. Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol. 70, 1167\u20131172 (2013).","journal-title":"JAMA Neurol."},{"key":"BFnrneurol2017185_CR223","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1447-0594.2012.00880.x","volume":"13","author":"N Tomita","year":"2013","unstructured":"Tomita, N. et al. Brain accumulation of amyloid-\u03b2 protein visualized by positron emission tomography and BF-227 in Alzheimer's disease patients with or without diabetes mellitus. Geriatr. Gerontol. Int. 13, 215\u2013221 (2013).","journal-title":"Geriatr. Gerontol. Int."},{"key":"BFnrneurol2017185_CR224","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jns.2014.12.023","volume":"349","author":"R Fukasawa","year":"2015","unstructured":"Fukasawa, R. et al. Identification of diabetes-related dementia: longitudinal perfusion SPECT and amyloid PET studies. J. Neurol. Sci. 349, 45\u201351 (2015).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol2017185_CR225","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3233\/JAD-150072","volume":"46","author":"EJ Starks","year":"2015","unstructured":"Starks, E. J. et al. Insulin resistance is associated with higher cerebrospinal fluid tau levels in asymptomatic APO\u03b54 Carriers. J. Alzheimers Dis. 46, 525\u2013533 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2017185_CR226","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1212\/WNL.49.5.1306","volume":"49","author":"J Heitner","year":"1997","unstructured":"Heitner, J. & Dickson, D. Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49, 1306\u20131311 (1997).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR227","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1212\/01.wnl.0000324925.95210.6d","volume":"71","author":"MS Beeri","year":"2008","unstructured":"Beeri, M. S. et al. Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology 71, 750\u2013757 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR228","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/archneurol.2008.579","volume":"66","author":"JA Sonnen","year":"2009","unstructured":"Sonnen, J. A. et al. Different patterns of cerebral injury in dementia with or without diabetes. Arch. Neurol. 66, 315\u2013322 (2009).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2017185_CR229","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1212\/01.wnl.0000247053.45483.4e","volume":"67","author":"Z Arvanitakis","year":"2006","unstructured":"Arvanitakis, Z. et al. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 67, 1960\u20131965 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol2017185_CR230","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.bbadis.2008.08.005","volume":"1792","author":"PT Nelson","year":"2009","unstructured":"Nelson, P. T. et al. Human cerebral neuropathology of Type 2 diabetes mellitus. Biochim. Biophys. Acta 1792, 454\u2013469 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneurol2017185_CR231","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jalz.2015.12.006","volume":"12","author":"EL Abner","year":"2016","unstructured":"Abner, E. L. et al. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 12, 882\u2013889 (2016).","journal-title":"Alzheimers Dement."},{"key":"BFnrneurol2017185_CR232","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2174\/15672050113109990006","volume":"10","author":"M Malek-Ahmadi","year":"2013","unstructured":"Malek-Ahmadi, M. et al. Increased Alzheimer's disease neuropathology is associated with type 2 diabetes and ApoE \u03b54 carrier status. Curr. Alzheimer Res. 10, 654\u2013659 (2013).","journal-title":"Curr. Alzheimer Res."},{"key":"BFnrneurol2017185_CR233","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neurobiolaging.2016.07.021","volume":"48","author":"PK Crane","year":"2016","unstructured":"Crane, P. K. et al. Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes. Neurobiol. Aging 48, 72\u201382 (2016).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2017185_CR234","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00005072-197304000-00001","volume":"32","author":"SM Aronson","year":"1973","unstructured":"Aronson, S. M. Intracranial vascular lesions in patients with diabetes mellitus. J. Neuropathol. Exp. Neurol. 32, 183\u2013196 (1973).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"BFnrneurol2017185_CR235","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1365-2990.2008.00948.x","volume":"35","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff, I., Aho, L., Helisalmi, S., Mannermaa, A. & Soininen, H. \u03b2-Amyloid deposition in brains of subjects with diabetes. Neuropathol. Appl. Neurobiol. 35, 60\u201368 (2009).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"BFnrneurol2017185_CR236","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.euroneuro.2014.01.019","volume":"24","author":"E Guerrero-Berroa","year":"2014","unstructured":"Guerrero-Berroa, E., Schmeidler, J. & Beeri, M. S. Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms. Eur. Neuropsychopharmacol 24, 1961\u20131966 (2014).","journal-title":"Eur. Neuropsychopharmacol"},{"key":"BFnrneurol2017185_CR237","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/epirev\/mxs012","volume":"35","author":"NT Vagelatos","year":"2013","unstructured":"Vagelatos, N. T. & Eslick, G. D. Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol. Rev. 35, 152\u2013160 (2013).","journal-title":"Epidemiol. Rev."},{"key":"BFnrneurol2017185_CR238","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N. Engl. J. Med. 367, 795\u2013804 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2017185_CR239","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.neurobiolaging.2013.09.033","volume":"35","author":"JK Morris","year":"2014","unstructured":"Morris, J. K., Vidoni, E. D., Honea, R. A., Burns, J. M. & Alzheimer's Disease Neuroimaging Initiative. Impaired glycemia increases disease progression in mild cognitive impairment. Neurobiol. Aging 35, 585\u2013589 (2014).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2017185_CR240","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neurobiolaging.2016.04.017","volume":"44","author":"JK Morris","year":"2016","unstructured":"Morris, J. K. et al. Impaired fasting glucose is associated with increased regional cerebral amyloid. Neurobiol. Aging 44, 138\u2013142 (2016).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2017185_CR241","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1475-2840-11-36","volume":"11","author":"R Chaudhary","year":"2012","unstructured":"Chaudhary, R. et al. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc. Diabetol. 11, 36 (2012).","journal-title":"Cardiovasc. Diabetol."},{"key":"BFnrneurol2017185_CR242","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-016-0329-1","volume":"15","author":"D El-Lebedy","year":"2016","unstructured":"El-Lebedy, D., Raslan, H. M. & Mohammed, A. M. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease. Cardiovasc. Diabetol 15, 12 (2016).","journal-title":"Cardiovasc. Diabetol"},{"key":"BFnrneurol2017185_CR243","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1093\/hmg\/ddv264","volume":"24","author":"KL Mohlke","year":"2015","unstructured":"Mohlke, K. L. & Boehnke, M. Recent advances in understanding the genetic architecture of type 2 diabetes. Hum. Mol. Genet. 24, R85\u2013R92 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol2017185_CR244","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dna.2015.2883","volume":"35","author":"N Kaul","year":"2016","unstructured":"Kaul, N. & Ali, S. Genes, genetics, and environment in type 2 diabetes: implication in personalized medicine. DNA Cell Biol. 35, 1\u201312 (2016).","journal-title":"DNA Cell Biol."},{"key":"BFnrneurol2017185_CR245","first-page":"926713","volume":"2014","author":"X Sun","year":"2014","unstructured":"Sun, X., Yu, W. & Hu, C. Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application. Biomed. Res. Int. 2014, 926713 (2014).","journal-title":"Biomed. Res. Int."},{"key":"BFnrneurol2017185_CR246","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/B978-0-12-800149-3.00005-6","volume":"87","author":"V Chouraki","year":"2014","unstructured":"Chouraki, V. & Seshadri, S. Genetics of Alzheimer's disease. Adv. Genet. 87, 245\u2013294 (2014).","journal-title":"Adv. Genet."},{"key":"BFnrneurol2017185_CR247","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch, C. M. & Goate, A. M. Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry 77, 43\u201351 (2015).","journal-title":"Biol. Psychiatry"},{"key":"BFnrneurol2017185_CR248","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.2337\/db06-1677","volume":"56","author":"MO Goodarzi","year":"2007","unstructured":"Goodarzi, M. O. et al. SORCS1: a novel human type 2 diabetes susceptibility gene suggested by the mouse. Diabetes 56, 1922\u20131929 (2007).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR249","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/humu.20953","volume":"30","author":"X Liang","year":"2009","unstructured":"Liang, X. et al. Genomic convergence to identify candidate genes for Alzheimer disease on chromosome 10. Hum. Mutat. 30, 463\u2013471 (2009).","journal-title":"Hum. Mutat."},{"key":"BFnrneurol2017185_CR250","doi-asserted-by":"publisher","first-page":"13110","DOI":"10.1523\/JNEUROSCI.3872-10.2010","volume":"30","author":"RF Lane","year":"2010","unstructured":"Lane, R. F. et al. Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex. J. Neurosci. 30, 13110\u201313115 (2010).","journal-title":"J. Neurosci."},{"key":"BFnrneurol2017185_CR251","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2337\/diacare.4.4.493","volume":"4","author":"RA DeFronzo","year":"1981","unstructured":"DeFronzo, R. A. Glucose intolerance and aging. Diabetes Care 4, 493\u2013501 (1981).","journal-title":"Diabetes Care"},{"key":"BFnrneurol2017185_CR252","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2337\/diab.40.1.44","volume":"40","author":"H Shimokata","year":"1991","unstructured":"Shimokata, H. et al. Age as independent determinant of glucose tolerance. Diabetes 40, 44\u201351 (1991).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR253","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.2337\/diabetes.52.6.1475","volume":"52","author":"JB Meigs","year":"2003","unstructured":"Meigs, J. B. et al. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 52, 1475\u20131484 (2003).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR254","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2337\/diab.45.7.947","volume":"45","author":"E Ferrannini","year":"1996","unstructured":"Ferrannini, E. et al. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45, 947\u2013953 (1996).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR255","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/JAD-2005-8304","volume":"8","author":"EJ Rivera","year":"2005","unstructured":"Rivera, E. J. et al. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine. J. Alzheimers Dis. 8, 247\u2013268 (2005).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2017185_CR256","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","volume":"31","author":"AM Moloney","year":"2010","unstructured":"Moloney, A. M. et al. Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol. Aging 31, 224\u2013243 (2010).","journal-title":"Neurobiol. Aging"},{"key":"BFnrneurol2017185_CR257","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s007020050067","volume":"105","author":"S Hoyer","year":"1998","unstructured":"Hoyer, S. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J. Neural Transm. (Vienna) 105, 415\u2013422 (1998).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"BFnrneurol2017185_CR258","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/BF01258634","volume":"75","author":"S Hoyer","year":"1989","unstructured":"Hoyer, S. & Nitsch, R. Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type. J. Neural Transm. 75, 227\u2013232 (1989).","journal-title":"J. Neural Transm."},{"key":"BFnrneurol2017185_CR259","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-2009-0995","volume":"16","author":"M Tong","year":"2009","unstructured":"Tong, M., Dong, M. & de la Monte, S. M. Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity. J. Alzheimers Dis. 16, 585\u2013599 (2009).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2017185_CR260","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-002-0657-y","volume":"105","author":"JJ Pei","year":"2003","unstructured":"Pei, J. J. et al. Role of protein kinase B in Alzheimer's neurofibrillary pathology. Acta Neuropathol. 105, 381\u2013392 (2003).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2017185_CR261","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1097\/00001756-200404290-00005","volume":"15","author":"A Rickle","year":"2004","unstructured":"Rickle, A. et al. Akt activity in Alzheimer's disease and other neurodegenerative disorders. Neuroreport 15, 955\u2013959 (2004).","journal-title":"Neuroreport"},{"key":"BFnrneurol2017185_CR262","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1111\/j.1742-4658.2005.04833.x","volume":"272","author":"X Li","year":"2005","unstructured":"Li, X., Alafuzoff, I., Soininen, H., Winblad, B. & Pei, J. J. Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain. FEBS J. 272, 4211\u20134220 (2005).","journal-title":"FEBS J."},{"key":"BFnrneurol2017185_CR263","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1471-4159.2004.02949.x","volume":"93","author":"RJ Griffin","year":"2005","unstructured":"Griffin, R. J. et al. Activation of Akt\/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J. Neurochem. 93, 105\u2013117 (2005).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2017185_CR264","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1586\/ern.10.40","volume":"10","author":"J Avila","year":"2010","unstructured":"Avila, J., Wandosell, F. & Hernandez, F. Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors. Expert Rev. Neurother 10, 703\u2013710 (2010).","journal-title":"Expert Rev. Neurother"},{"key":"BFnrneurol2017185_CR265","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","volume":"104","author":"C Hooper","year":"2008","unstructured":"Hooper, C., Killick, R. & Lovestone, S. The GSK3 hypothesis of Alzheimer's disease. J. Neurochem. 104, 1433\u20131439 (2008).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2017185_CR266","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim, T. R. et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Abeta oligomers. J. Clin. Invest. 122, 1339\u20131353 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrneurol2017185_CR267","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-014-1328-5","volume":"128","author":"M Yarchoan","year":"2014","unstructured":"Yarchoan, M. et al. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies. Acta Neuropathol. 128, 679\u2013689 (2014).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2017185_CR268","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/jnc.13037","volume":"133","author":"A Tramutola","year":"2015","unstructured":"Tramutola, A. et al. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD. J. Neurochem. 133, 739\u2013749 (2015).","journal-title":"J. Neurochem."},{"key":"BFnrneurol2017185_CR269","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/bpa.12388","volume":"27","author":"M Taga","year":"2017","unstructured":"Taga, M. et al. Metaflammasome components in the human brain: a role in dementia with alzheimer's pathology? Brain Pathol. 27, 266\u2013275 (2017).","journal-title":"Brain Pathol."},{"key":"BFnrneurol2017185_CR270","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/BF00313602","volume":"87","author":"I Moroo","year":"1994","unstructured":"Moroo, I. et al. Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease. Acta Neuropathol. 87, 343\u2013348 (1994).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol2017185_CR271","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0304-3940(96)12357-0","volume":"204","author":"M Takahashi","year":"1996","unstructured":"Takahashi, M. et al. Insulin receptor mRNA in the substantia nigra in Parkinson's disease. Neurosci. Lett. 204, 201\u2013204 (1996).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol2017185_CR272","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neulet.2009.09.055","volume":"467","author":"S Timmons","year":"2009","unstructured":"Timmons, S., Coakley, M. F., Moloney, A. M. & O'Neill C. Akt signal transduction dysfunction in Parkinson's disease. Neurosci. Lett. 467, 30\u201335 (2009).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol2017185_CR273","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3233\/JAD-161256","volume":"57","author":"S Craft","year":"2017","unstructured":"Craft, S. et al. Effects of regular and long-acting insulin on cognition and alzheimer's disease biomarkers: a pilot clinical trial. J. Alzheimers Dis. 57, 1325\u20131334 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2017185_CR274","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.2337\/db14-0287","volume":"63","author":"M Yarchoan","year":"2014","unstructured":"Yarchoan, M. & Arnold, S. E. Repurposing diabetes drugs for brain insulin resistance in Alzheimer disease. Diabetes 63, 2253\u20132261 (2014).","journal-title":"Diabetes"},{"key":"BFnrneurol2017185_CR275","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JAD-150493","volume":"51","author":"JA Luchsinger","year":"2016","unstructured":"Luchsinger, J. A. et al. Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial. J. Alzheimers Dis. 51, 501\u2013514 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"BFnrneurol2017185_CR276","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/WAD.0000000000000202","volume":"31","author":"AM Koenig","year":"2017","unstructured":"Koenig, A. M. et al. Effects of the insulin sensitizer metformin in alzheimer disease: pilot data from a randomized placebo-controlled crossover study. Alzheimer Dis. Assoc. Disord. 31, 107\u2013113 (2017).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"BFnrneurol2017185_CR277","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.bbrc.2016.08.043","volume":"483","author":"S Agarwal","year":"2017","unstructured":"Agarwal, S., Yadav, A. & Chaturvedi, R. K. Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders. Biochem. Biophys. Res. Commun. 483, 1166\u20131177 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrneurol2017185_CR278","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2174\/156720511796391935","volume":"8","author":"C Harrington","year":"2011","unstructured":"Harrington, C. et al. Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies. Curr. Alzheimer Res. 8, 592\u2013606 (2011).","journal-title":"Curr. Alzheimer Res."},{"key":"BFnrneurol2017185_CR279","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1515\/revneuro-2016-0018","volume":"27","author":"Y Li","year":"2016","unstructured":"Li, Y., Li, L. & Holscher, C. Incretin-based therapy for type 2 diabetes mellitus is promising for treating neurodegenerative diseases. Rev. Neurosci. 27, 689\u2013711 (2016).","journal-title":"Rev. Neurosci."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2017.185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2017.185","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrneurol.2017.185","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2017.185.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T15:58:34Z","timestamp":1719763114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2017.185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,29]]},"references-count":279,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["BFnrneurol2017185"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2017.185","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732579862.793572336","asserted-by":"object"}]},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,29]]},"assertion":[{"value":"29 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}